Indo euro indchem Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The certificate covers the quarter ended March 31, 2026, and was filed on April 15, 2026.

Regulatory Compliance Details

The certificate was issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, which mandates specific compliance requirements for listed companies regarding dematerialization processes. The document confirms that all securities received from depository participants for dematerialization during March 2026 were properly processed within prescribed timelines.

Certificate Issuance and Verification

Purva Shareregistry (I) Pvt. Ltd., serving as the company's Registrar and Share Transfer Agent, issued the compliance certificate. The RTA confirmed that securities received for dematerialization were properly accepted or rejected, and that all security certificates were mutilated and cancelled after due verification by depository participants.

The certificate also confirms that depositories' names were substituted in the register of members as registered owners within the prescribed timelines, ensuring full compliance with regulatory requirements.

Corporate Governance

Managing Director Vardhman Shah, holding DIN 00334194, signed and submitted the certificate to BSE Limited's Department of Corporate Services. The submission included digital signatures and proper authentication, demonstrating the company's commitment to maintaining transparent corporate governance practices.

The filing represents routine compliance with SEBI regulations, ensuring that Indo Euro Indchem Limited maintains its good standing with regulatory authorities and continues to meet all mandatory disclosure requirements for the quarter ended March 31, 2026.

Indo euro indchem Limited has submitted revised unaudited financial results for the second quarter and half year ended September 30, 2025, following discrepancies identified by BSE Limited in February 2026. The chemical trading company demonstrated strong quarterly performance with significant year-on-year growth across key financial metrics.

Quarterly Financial Performance

The company's Q2FY26 results showed remarkable improvement compared to the corresponding quarter of the previous year:

The substantial revenue growth was primarily driven by increased purchases of stock-in-trade, which rose to ₹110.64 lakhs from ₹69.51 lakhs in Q2FY25. Other income remained relatively stable at ₹14.80 lakhs compared to ₹20.14 lakhs in the previous year.

Half Year Performance Analysis

For the six-month period ended September 30, 2025, the company's performance showed mixed results:

Despite the decline in revenue for the half year period, the company managed to maintain profitability and achieve modest growth in net profit.

Expense Management and Operational Efficiency

The company's expense structure for Q2FY26 totaled ₹283.55 lakhs compared to ₹109.44 lakhs in Q2FY25. Key expense components included:

• Purchases of stock-in-trade: ₹110.64 lakhs
• Other expenses: ₹110.23 lakhs
• Changes in inventories: ₹49.07 lakhs
• Employee benefits expense: ₹13.05 lakhs

The company maintained minimal finance costs and depreciation expenses, reflecting efficient capital management.

Balance Sheet Position

As of September 30, 2025, the company's financial position showed:

The significant reduction in trade receivables from ₹1,385.66 lakhs to ₹743.50 lakhs indicates improved collection efficiency.

Corporate Governance and Compliance

The revised financial results were reviewed by the audit committee and approved by the Board of Directors at their meeting held on November 13, 2025. The results have been prepared in accordance with Indian Accounting Standards and SEBI regulations. The company operates in a single business segment of trading in chemicals and others, making segment-wise disclosure not applicable under Ind AS-108.